CORZYNA

Identification of Corzyna

No description

Google image searchProduct monograph

Active ingredient

ranolazine, 1000 MG

DIN: 02510227

Dosage form(s): TABLET (EXTENDED-RELEASE)

Route(s) of administration: ORAL

Schedule: Prescription

Company: KYE PHARMACEUTICALS INC.

Date: 24-MAY-2023

ATC:

Reference brand drug: Corzyna

Search on Google